Evidence map›Paper›PMID 42063718›Full record

ArticleFrontiers in oncology2026

Awareness of lung cancer screening among smokers: a Lebanese experience.

Karl Rizk, Bachir Atallah, Maissa Safieddine, Joseph Kattan

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karl RizkUniversity Medical Center Hotel-Dieu de France, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
Bachir AtallahClinical Research Center, Faculty of Medicine Saint Joseph University of Beirut, Beirut, Lebanon.
Maissa SafieddineClinical Research Center, Faculty of Medicine Saint Joseph University of Beirut, Beirut, Lebanon.
Joseph KattanDepartment of Hematology-Oncology, University Medical Center Hotel-Dieu de France, Faculty of Medicine, Saint-Joseph University of Beirut, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lung cancer remains the leading cause of cancer-related mortality worldwide, largely due to late diagnosis, despite strong evidence that low-dose computed tomography (LDCT) reduces mortality and morbidity associated with lung cancer. The effectiveness of screening heavily relies on public awareness and participation. In Lebanon, where tobacco use is prevalent, and no national lung cancer screening program exists, data on LDCT awareness and uptake are limited. Objectives: This study aims, on one hand, to evaluate awareness and uptake of LDCT screening among Lebanese individuals at risk and, on the other hand, to identify factors associated with knowledge and screening behavior. Methods: A cross-sectional survey was conducted in Lebanon between December 1, 2024, and December 1, 2025, among current and former Lebanese smokers aged 40 years and older. A structured questionnaire was developed in both online and in-person forms, and collected information on sociodemographic characteristics, smoking history, awareness of LDCT screening, previous screening, and perceived barriers. Results: 242 eligible participants filled the questionnaire. Only 21.1% of participants reported prior knowledge of LDCT screening, and 9.9% had previously undergone screening. The strongest independent predictor of awareness was a higher educational level. LDCT uptake was strongly associated with prior knowledge of the test, male sex, higher socioeconomic status, and active smoking. The most commonly reported barriers included a lack of information and low perceived personal risk, particularly among former smokers. Conclusion: A significant gap was seen between the proven benefits of LDCT screening and its implementation in Lebanon. These findings highlight the need for education, centered on physicians, targeted public health campaigns, and the formation of a national lung cancer prevention strategy with LDCT to reduce avoidable morbidity and mortality.

Indexed as

awarenesslow-dose computed tomographylung cancerlung cancer screeningsmoking

Identifiers

PMID42063718
PMCPMC13124535

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.